How do you prepare your pharmacy for a natural disaster?
How does a pharmacy weather a flood, with a community relying on ongoing care? Bridget Totterman and Rachel Hetherington shared their personal experiences and lessons at PSA25 When major flooding …
‘The time for reviews is over’
The opposition health spokeswoman reaffirmed her commitment to holding the government to account on implementing the full scope review at PSA25 Policymakers must ensure “every single health professional is operating …
US headwinds soften MedAdvisor profit
Community pharmacy in the US is facing new competition from digital entrants such as Amazon, while market uncertainty is affecting vaccine uptake, the ASX-listed company says Pharmacy software company MedAdvisor …
Lived experience influences at-risk screening: study
How does a pharmacist’s own experiences with mental health affect how they screen and respond to at-risk patients? Researchers in Western Australia investigated Pharmacists’ lived experience with suicide affects how …
MedAdvisor reviews CEO incentives
The pharmacy technology company’s shareholders will vote on plans to link part of the CEO’s benefits to long-term market performance MedAdvisor investors will look at giving the company’s CEO …
MedAdvisor considers US sale
In the aftermath of selling its local business, pharmacy software company MedAdvisor is still reviewing its strategic options, which may include offloading its US arm MedAdvisor Solutions has appointed a …
Cost sees patients skip meds or care: report
Almost one-in-five Australians with chronic conditions have foregone medication or care due to cost, according to a landmark international survey Price and distance have emerged as two of the main …
CWH founder’s Sigma wealth revealed
Mario Verrocchi has made his debut on the Australian Financial Review’s Rich Bosses list, which gives the market a glimpse of his enormous post-merger shareholder wealth Chemist Warehouse co-founder Mario …
Pharmx renews diabetes scheme deal
The pharmacy ordering platform says the renewal will help it to hit growth objectives Pharmx has locked in a 12-month extension to its supplier arrangement with the National Diabetes Services …
‘The introduction of tariffs does not make sense’
Estimates suggest a 200% tariff on pharmaceuticals could strip billions from the Australian economy, with authorities seeking clarity on what it would mean for local markets US President Donald Trump …
PBS targeted by US drug lobby
A powerful US pharma lobby group has come after Australia’s PBS, claiming it sets drug prices too low – and should pay the price, a report shows The Pharmaceutical Research …
